Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

USA - NYSE:COHR - US19247G1076 - Common Stock

104.47 USD
-1.87 (-1.76%)
Last: 9/16/2025, 8:07:52 PM
104.47 USD
0 (0%)
After Hours: 9/16/2025, 8:07:52 PM
Fundamental Rating

4

Overall COHR gets a fundamental rating of 4 out of 10. We evaluated COHR against 125 industry peers in the Electronic Equipment, Instruments & Components industry. COHR has a medium profitability rating, but doesn't score so well on its financial health evaluation. COHR is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COHR had positive earnings in the past year.
In the past year COHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: COHR reported negative net income in multiple years.
COHR had a positive operating cash flow in each of the past 5 years.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

The Return On Assets of COHR (-0.54%) is comparable to the rest of the industry.
COHR's Return On Equity of -0.99% is in line compared to the rest of the industry. COHR outperforms 50.40% of its industry peers.
COHR has a Return On Invested Capital of 3.62%. This is comparable to the rest of the industry: COHR outperforms 56.00% of its industry peers.
COHR had an Average Return On Invested Capital over the past 3 years of 1.91%. This is significantly below the industry average of 9.48%.
The 3 year average ROIC (1.91%) for COHR is below the current ROIC(3.62%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.54%
ROE -0.99%
ROIC 3.62%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.91%
ROIC(5y)3.38%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

Looking at the Operating Margin, with a value of 10.34%, COHR is in the better half of the industry, outperforming 76.80% of the companies in the same industry.
COHR's Operating Margin has improved in the last couple of years.
COHR has a Gross Margin (35.17%) which is in line with its industry peers.
In the last couple of years the Gross Margin of COHR has remained more or less at the same level.
Industry RankSector Rank
OM 10.34%
PM (TTM) N/A
GM 35.17%
OM growth 3Y-9.74%
OM growth 5Y23.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

3

2. Health

2.1 Basic Checks

COHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for COHR has been increased compared to 1 year ago.
The number of shares outstanding for COHR has been increased compared to 5 years ago.
The debt/assets ratio for COHR has been reduced compared to a year ago.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

The Debt to FCF ratio of COHR is 19.13, which is on the high side as it means it would take COHR, 19.13 years of fcf income to pay off all of its debts.
COHR has a Debt to FCF ratio of 19.13. This is comparable to the rest of the industry: COHR outperforms 52.80% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that COHR is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.43, COHR is not doing good in the industry: 62.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 19.13
Altman-Z N/A
ROIC/WACC0.39
WACC9.3%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

COHR has a Current Ratio of 2.19. This indicates that COHR is financially healthy and has no problem in meeting its short term obligations.
COHR has a Current ratio of 2.19. This is comparable to the rest of the industry: COHR outperforms 48.00% of its industry peers.
COHR has a Quick Ratio of 1.39. This is a normal value and indicates that COHR is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.39, COHR is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.39
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.87% over the past year.
COHR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.89% yearly.
Looking at the last year, COHR shows a very strong growth in Revenue. The Revenue has grown by 23.42%.
Measured over the past years, COHR shows a quite strong growth in Revenue. The Revenue has been growing by 19.54% on average per year.
EPS 1Y (TTM)116.87%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%63.93%
Revenue 1Y (TTM)23.42%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%16.39%

3.2 Future

The Earnings Per Share is expected to grow by 27.30% on average over the next years. This is a very strong growth
COHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.90% yearly.
EPS Next Y29.83%
EPS Next 2Y23.21%
EPS Next 3Y27.3%
EPS Next 5YN/A
Revenue Next Year8.74%
Revenue Next 2Y7.94%
Revenue Next 3Y9.9%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.02, COHR can be considered very expensive at the moment.
Based on the Price/Earnings ratio, COHR is valued a bit cheaper than 64.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of COHR to the average of the S&P500 Index (27.20), we can say COHR is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 22.35, the valuation of COHR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, COHR is valued a bit cheaper than the industry average as 64.00% of the companies are valued more expensively.
COHR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 29.02
Fwd PE 22.35
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

COHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COHR is cheaper than 68.00% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as COHR.
Industry RankSector Rank
P/FCF 84.44
EV/EBITDA 16.76
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

COHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COHR's earnings are expected to grow with 27.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.97
PEG (5Y)4.21
EPS Next 2Y23.21%
EPS Next 3Y27.3%

0

5. Dividend

5.1 Amount

COHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COHERENT CORP

NYSE:COHR (9/16/2025, 8:07:52 PM)

After market: 104.47 0 (0%)

104.47

-1.87 (-1.76%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners94.79%
Inst Owner Change1.29%
Ins Owners0.6%
Ins Owner Change3.74%
Market Cap16.28B
Analysts81.38
Price Target114.74 (9.83%)
Short Float %5.27%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-14.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.73%
Min EPS beat(2)4.19%
Max EPS beat(2)7.27%
EPS beat(4)4
Avg EPS beat(4)15.98%
Min EPS beat(4)4.19%
Max EPS beat(4)34.28%
EPS beat(8)8
Avg EPS beat(8)19.38%
EPS beat(12)11
Avg EPS beat(12)12.81%
EPS beat(16)15
Avg EPS beat(16)10.72%
Revenue beat(2)1
Avg Revenue beat(2)0.67%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)2.33%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)8
Avg Revenue beat(16)-0.71%
PT rev (1m)8.03%
PT rev (3m)16.94%
EPS NQ rev (1m)2.39%
EPS NQ rev (3m)4.36%
EPS NY rev (1m)1.71%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)1.43%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 29.02
Fwd PE 22.35
P/S 2.8
P/FCF 84.44
P/OCF 25.69
P/B 2
P/tB 36.01
EV/EBITDA 16.76
EPS(TTM)3.6
EY3.45%
EPS(NY)4.67
Fwd EY4.47%
FCF(TTM)1.24
FCFY1.18%
OCF(TTM)4.07
OCFY3.89%
SpS37.29
BVpS52.16
TBVpS2.9
PEG (NY)0.97
PEG (5Y)4.21
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -0.99%
ROCE 4.58%
ROIC 3.62%
ROICexc 3.89%
ROICexgc 10.47%
OM 10.34%
PM (TTM) N/A
GM 35.17%
FCFM 3.32%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.91%
ROIC(5y)3.38%
ROICexc(3y)2.05%
ROICexc(5y)4.61%
ROICexgc(3y)5.86%
ROICexgc(5y)10.02%
ROCE(3y)2.42%
ROCE(5y)4.28%
ROICexcg growth 3Y-16.13%
ROICexcg growth 5Y26.18%
ROICexc growth 3Y-25.01%
ROICexc growth 5Y18.65%
OM growth 3Y-9.74%
OM growth 5Y23.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 19.13
Debt/EBITDA 3.03
Cap/Depr 79.63%
Cap/Sales 7.59%
Interest Coverage 2.34
Cash Conversion 54.9%
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 1.39
Altman-Z N/A
F-Score6
WACC9.3%
ROIC/WACC0.39
Cap/Depr(3y)68.52%
Cap/Depr(5y)73.87%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.87%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%63.93%
EPS Next Y29.83%
EPS Next 2Y23.21%
EPS Next 3Y27.3%
EPS Next 5YN/A
Revenue 1Y (TTM)23.42%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%16.39%
Revenue Next Year8.74%
Revenue Next 2Y7.94%
Revenue Next 3Y9.9%
Revenue Next 5YN/A
EBIT growth 1Y186.09%
EBIT growth 3Y8.81%
EBIT growth 5Y48.06%
EBIT Next Year47.4%
EBIT Next 3Y24.63%
EBIT Next 5YN/A
FCF growth 1Y-3.09%
FCF growth 3Y24.87%
FCF growth 5Y4.23%
OCF growth 1Y16.1%
OCF growth 3Y15.31%
OCF growth 5Y16.34%